Last reviewed · How we verify
Baclofen bolus injection
At a glance
| Generic name | Baclofen bolus injection |
|---|---|
| Also known as | Injection of baclofen bolus |
| Sponsor | Vanderbilt University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Intrathecal (IT) Baclofen Drug Distribution (PHASE4)
- Intrathecal Baclofen (ITB) Bolus on Neuropathic Pain (NP). Preliminary Study. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Baclofen bolus injection CI brief — competitive landscape report
- Baclofen bolus injection updates RSS · CI watch RSS
- Vanderbilt University portfolio CI